Cc chemokines in idiopathic pulmonary fibrosis: pathogenic role and therapeutic potential

HIGHLIGHTS

• who: Shanshan Liu and colleagues from the Central South University, Changsha, China have published the research: CC Chemokines in Idiopathic Pulmonary Fibrosis: Pathogenic Role and Therapeutic Potential, in the Journal: Biomolecules 2023, 13, 333. of /2023/
• what: Chronic inflammation within the respiratory tract may arise from the combination of diverse environmental insults and genetic susceptibility, and this inflammation underlies the pathogenesis of numerous chronic pulmonary diseases, such as IPF [105].
• future: As the pathogenesis of IPF 13 of 20 in humans is undoubtedly more complicated than that in animal models additional clinical trials . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.